78 related articles for article (PubMed ID: 32825295)
1. Low Incidence of SARS-CoV-2 in Patients with Solid Tumours on Active Treatment: An Observational Study at a Tertiary Cancer Centre in Lombardy, Italy.
Bertuzzi AF; Marrari A; Gennaro N; Cariboni U; Ciccarelli M; Giordano L; Quagliuolo VL; Santoro A
Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32825295
[No Abstract] [Full Text] [Related]
2. Circulating TNF-RII, IP-10 and HGF are associated with severity of COVID-19 in oncologic patients.
Carrillo-García J; Lacerenza S; Hindi N; Moura DS; Marquina G; Parra Corral D; Olalla J; María Cano Cano J; Hoyos S; Renshaw M; Mondaza-Hernández JL; Di Lernia D; Casado A; Manzano A; Gutierrez A; Martin-Broto J
Cytokine; 2024 May; 177():156542. PubMed ID: 38364458
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry.
Garrigós L; Saura C; Martinez-Vila C; Zambelli A; Bower M; Pistilli B; Lambertini M; Ottaviani D; Diamantis N; Lumsden A; Pernas S; Generali D; Seguí E; Viñas G; Felip E; Sanchez A; Rizzo G; Santoro A; Cortellini A; Perone Y; Chester J; Iglesias M; Betti M; Vincenzi B; Libertini M; Mazzoni F; Zoratto F; Berardi R; Guida A; Wuerstlein R; Loizidou A; Sharkey R; Aguilar Company J; Matas M; Saggia C; Chiudinelli L; Colomba-Blameble E; Galazi M; Mukherjee U; Van Hemelrijck M; Marin M; Strina C; Prat A; Pla H; Ciruelos EM; Bertuzzi A; Del Mastro L; Porzio G; Newsom-Davis T; Ruiz I; Delany MB; Krengli M; Fotia V; Viansone A; Chopra N; Romeo M; Salazar R; Perez I; d'Avanzo F; Franchi M; Milani M; Pommeret F; Tucci M; Pedrazzoli P; Harbeck N; Ferrante D; Pinato DJ; Gennari A
Ther Adv Med Oncol; 2021; 13():17588359211053416. PubMed ID: 34777582
[TBL] [Abstract][Full Text] [Related]
4. Synergistic Action of Immunotherapy and Nanotherapy against Cancer Patients Infected with SARS-CoV-2 and the Use of Artificial Intelligence.
Gupta T; Debele TA; Wei YF; Gupta A; Murtaza M; Su WP
Cancers (Basel); 2022 Jan; 14(1):. PubMed ID: 35008377
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 in cancer patients on active systemic therapy - Outcomes from LMIC scenario with an emphasis on need for active treatment.
Ramaswamy A; Nayak L; Roy Moulik N; Sengar M; Chinnaswamy G; Jobanputra K; Shah MJ; Kapoor A; Joshi A; Kumar A; Gokarn A; Bonda A; Cheriyalinkal Parambil B; Prasad M; Bagal B; Dhamne C; Narula G; Jain H; Ghosh J; Thorat J; Bajpai J; Menon N; Khattry N; Bhargava P; Punatar S; Gulia S; Banavali S; Gupta S; Srinivas S; Rath S; Vora T; Noronha V; Patil VM; Ostwal V; Prabhash K
Cancer Med; 2020 Dec; 9(23):8747-8753. PubMed ID: 33128509
[TBL] [Abstract][Full Text] [Related]
6. Multivariate mortality analyses in COVID-19: Comparing patients with cancer and patients without cancer in Louisiana.
Lunski MJ; Burton J; Tawagi K; Maslov D; Simenson V; Barr D; Yuan H; Johnson D; Matrana M; Cole J; Larned Z; Moore B
Cancer; 2021 Jan; 127(2):266-274. PubMed ID: 33112411
[TBL] [Abstract][Full Text] [Related]
7. Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study.
García-Suárez J; de la Cruz J; Cedillo Á; Llamas P; Duarte R; Jiménez-Yuste V; Hernández-Rivas JÁ; Gil-Manso R; Kwon M; Sánchez-Godoy P; Martínez-Barranco P; Colás-Lahuerta B; Herrera P; Benito-Parra L; Alegre A; Velasco A; Matilla A; Aláez-Usón MC; Martos-Martínez R; Martínez-Chamorro C; Susana-Quiroz K; Del Campo JF; de la Fuente A; Herráez R; Pascual A; Gómez E; Pérez-Oteyza J; Ruiz E; Alonso A; González-Medina J; Martín-Buitrago LN; Canales M; González-Gascón I; Vicente-Ayuso MC; Valenciano S; Roa MG; Monteliu PE; López-Jiménez J; Escobar CE; Ortiz-Martín J; Diez-Martin JL; Martinez-Lopez J;
J Hematol Oncol; 2020 Oct; 13(1):133. PubMed ID: 33032660
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and Outcome of COVID-19 Infection in Cancer Patients: A National Veterans Affairs Study.
Fillmore NR; La J; Szalat RE; Tuck DP; Nguyen V; Yildirim C; Do NV; Brophy MT; Munshi NC
J Natl Cancer Inst; 2021 Jun; 113(6):691-698. PubMed ID: 33031532
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 in cancer patients: clinical characteristics and outcome-an analysis of the LEOSS registry.
Rüthrich MM; Giessen-Jung C; Borgmann S; Classen AY; Dolff S; Grüner B; Hanses F; Isberner N; Köhler P; Lanznaster J; Merle U; Nadalin S; Piepel C; Schneider J; Schons M; Strauss R; Tometten L; Vehreschild JJ; von Lilienfeld-Toal M; Beutel G; Wille K;
Ann Hematol; 2021 Feb; 100(2):383-393. PubMed ID: 33159569
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics and risk factors for in-hospital mortality of lung cancer patients with COVID-19: A multicenter, retrospective, cohort study.
Nie L; Dai K; Wu J; Zhou X; Hu J; Zhang C; Zhan Y; Song Y; Fan W; Hu Z; Yang H; Yang Q; Wu D; Li F; Li D; Nie R
Thorac Cancer; 2021 Jan; 12(1):57-65. PubMed ID: 33142039
[TBL] [Abstract][Full Text] [Related]
11. Association between recent oncologic treatment and mortality among patients with carcinoma who are hospitalized with COVID-19: A multicenter study.
Song K; Gong H; Xu B; Dong X; Li L; Hu W; Wang Q; Xie Z; Rao Z; Luo Z; Chu Q; Li F; Wang J
Cancer; 2021 Feb; 127(3):437-448. PubMed ID: 33136293
[TBL] [Abstract][Full Text] [Related]
12. Clinical Characteristics and Outcomes of COVID-19-Infected Cancer Patients: A Systematic Review and Meta-Analysis.
Zhang H; Han H; He T; Labbe KE; Hernandez AV; Chen H; Velcheti V; Stebbing J; Wong KK
J Natl Cancer Inst; 2021 Apr; 113(4):371-380. PubMed ID: 33136163
[TBL] [Abstract][Full Text] [Related]
13. Association of active oncologic treatment and risk of death in cancer patients with COVID-19: a systematic review and meta-analysis of patient data.
Park R; Lee SA; Kim SY; de Melo AC; Kasi A
Acta Oncol; 2021 Jan; 60(1):13-19. PubMed ID: 33131376
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19).
Lièvre A; Turpin A; Ray-Coquard I; Le Malicot K; Thariat J; Ahle G; Neuzillet C; Paoletti X; Bouché O; Aldabbagh K; Michel P; Debieuvre D; Canellas A; Wislez M; Laurent L; Mabro M; Colle R; Hardy-Bessard AC; Mansi L; Colomba E; Bourhis J; Gorphe P; Pointreau Y; Idbaih A; Ursu R; Di Stefano AL; Zalcman G; Aparicio T;
Eur J Cancer; 2020 Dec; 141():62-81. PubMed ID: 33129039
[TBL] [Abstract][Full Text] [Related]
15. Collateral effects of the coronavirus disease 2019 pandemic on lung cancer diagnosis in Korea.
Park JY; Lee YJ; Kim T; Lee CY; Kim HI; Kim JH; Park S; Hwang YI; Jung KS; Jang SH
BMC Cancer; 2020 Oct; 20(1):1040. PubMed ID: 33121456
[TBL] [Abstract][Full Text] [Related]
16. The Landscape of COVID-19 in Cancer Patients: Prevalence, Impacts, and Recommendations.
Abdihamid O; Cai C; Kapesa L; Zeng S
Cancer Manag Res; 2020; 12():8923-8933. PubMed ID: 33061588
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 in patients with cancer: managing a pandemic within a pandemic.
Horn L; Garassino M
Nat Rev Clin Oncol; 2021 Jan; 18(1):1-2. PubMed ID: 33060841
[TBL] [Abstract][Full Text] [Related]
18. Clinical risk factors for mortality in patients with cancer and COVID-19: a systematic review and meta-analysis of recent observational studies.
Liu Y; Lu H; Wang W; Liu Q; Zhu C
Expert Rev Anticancer Ther; 2021 Jan; 21(1):107-119. PubMed ID: 33054414
[TBL] [Abstract][Full Text] [Related]
19. High mortality among hospital-acquired COVID-19 infection in patients with cancer: A multicentre observational cohort study.
Elkrief A; Desilets A; Papneja N; Cvetkovic L; Groleau C; Lakehal YA; Shbat L; Richard C; Malo J; Belkaid W; Cook E; Doucet S; Tran TH; Jao K; Daaboul N; Bhang E; Loree JM; Miller WH; Vinh DC; Bouganim N; Batist G; Letendre C; Routy B
Eur J Cancer; 2020 Nov; 139():181-187. PubMed ID: 33035991
[TBL] [Abstract][Full Text] [Related]
20. Impact of solid cancer on in-hospital mortality overall and among different subgroups of patients with COVID-19: a nationwide, population-based analysis.
de Azambuja E; Brandão M; Wildiers H; Laenen A; Aspeslagh S; Fontaine C; Collignon J; Lybaert W; Verheezen J; Rutten A; Vuylsteke P; Goeminne JC; Demey W; Van Beckhoven D; Deblonde J; Rottey S; Geukens T; Punie K; ; Bafort K; Belkhir L; Bossuyt N; Colombie V; Daubresse C; Dauby N; De Munter P; Delmarcelle D; Delvallee M; Demeester R; Delefortrie Q; Dugernier T; Holemans X; Louviaux I; Machurot P; Minette P; Mokrane S; Nachtergal C; Noirhomme S; Piérard D; Rossi C; Schirvel C; Sermijn E; Staelens F; Triest F; Van Beckhoven D; Van Goethem N; Van Praet J; Vanhoenacker A; Verstraete R; Willems E; Wyndham-Thomas C
ESMO Open; 2020 Sep; 5(5):e000947. PubMed ID: 32978251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
